AKCOME vs Sunova - solar panel manufacturer comparison

Sunova Solar is a Chinese manufacturer founded in 2016 and headquartered in Wuxi, Jiangsu. Despite its relatively recent founding, Sunova has achieved Tier 1 status on Bloomberg NEF's module manufacturer list and reported an annual production capacity of approximately 6.5 GW as of early 2025, backed by facilities in China and Vietnam, with a new 9 GW cell factory announced in Yibin, Sichuan in early 2024. AKCOME Group is an older and larger enterprise, established in 2006 in Zhangjiagang, Jiangsu, and publicly listed on the Shenzhen Stock Exchange since 2011. AKCOME previously held Tier 1 status but was reported to have been removed from the BNEF list as of the 2024 rankings - a meaningful shift for lenders and project financiers. Its panel manufacturing capacity reached roughly 10 GW across multiple sites as of late 2023. On institutional footprint, Sunova currently holds the stronger bankability position owing to its active Tier 1 standing.

Sunova's product range spans residential rooftops, commercial and industrial installations, and utility-scale ground mounts, with confirmed TOPCon and HJT n-type cell technologies across its module families, offered in both monofacial and bifacial dual-glass configurations. AKCOME has staked out a more distinctive technological identity, positioning HJT heterojunction technology as its primary focus. The company achieved a mass-production HJT cell efficiency of 25.6% and has launched high-power modules exceeding 700 W, while also conducting early-stage research into perovskite-HJT tandem cells. AKCOME's portfolio targets commercial, industrial, and utility-scale applications where high module efficiency justifies the typically higher cost of HJT production.

For most buyers in 2025, Sunova is the lower-risk default: its active Tier 1 bankability simplifies project financing and insurance, and its broad product range suits the majority of installation types. AKCOME's HJT specialization is genuinely compelling for efficiency-constrained sites or buyers who prioritize cutting-edge cell technology, but its lapsed Tier 1 status is a practical hurdle on financed projects. The two brands are not interchangeable in the financing context, even if panel-level quality may remain competitive.

Generated by Claude Sonnet · 2026-06-11